I suspect Locust walked away from IPIX after Trader Leo could only pay them in useless IPIX stock and realizing there was nothing it could do for the salesman and his gold standard wonder drug.
At this pace late July/August remains correct for topline results. Whatever their results, the true question with IPIX is how do they leverage their results...that's been a wee bit of a problem for the last 14 years.
I would like an update on:
+Alfasigma partnership (is it still alive); are they getting any money from them?
+GI Oral Trial (is this still happening / when?)
+COVID "Further Lab Testing" (they said they were doing this 3.5 months ago; why have they not shared results?)
+Partnerships (any?)
+Locust Walk (what's the status of their relationship?)
+ Kevetrin (what's the plan for this asset?)
+ Oral Mucositis (any partnerships? / what's the plan for their Phase 3 trial?)
Market Data 
Markets 
AI
